vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and Getty Images Holdings, Inc. (GETY). Click either name above to swap in a different company.
Getty Images Holdings, Inc. is the larger business by last-quarter revenue ($282.3M vs $263.6M, roughly 1.1× BALCHEM CORP). BALCHEM CORP runs the higher net margin — 14.9% vs -32.2%, a 47.1% gap on every dollar of revenue. On growth, Getty Images Holdings, Inc. posted the faster year-over-year revenue change (14.1% vs 9.8%). Over the past eight quarters, Getty Images Holdings, Inc.'s revenue compounded faster (12.7% CAGR vs 4.9%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Getty Images Holdings, Inc. is a visual media company and supplier of stock images, editorial photography, video, and music for businesses and consumers, with a library of over 477 million assets. It targets three markets—creative professionals, the media, and corporate.
BCPC vs GETY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $263.6M | $282.3M |
| Net Profit | $39.2M | $-90.9M |
| Gross Margin | 35.6% | 74.8% |
| Operating Margin | 19.8% | -8.5% |
| Net Margin | 14.9% | -32.2% |
| Revenue YoY | 9.8% | 14.1% |
| Net Profit YoY | 16.8% | -467.6% |
| EPS (diluted) | $1.21 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $263.6M | $282.3M | ||
| Q3 25 | $267.6M | $240.0M | ||
| Q2 25 | $255.5M | $234.9M | ||
| Q1 25 | $250.5M | $224.1M | ||
| Q4 24 | $240.0M | $247.3M | ||
| Q3 24 | $239.9M | $240.5M | ||
| Q2 24 | $234.1M | $229.1M | ||
| Q1 24 | $239.7M | $222.3M |
| Q4 25 | $39.2M | $-90.9M | ||
| Q3 25 | $40.3M | $21.6M | ||
| Q2 25 | $38.3M | $-34.4M | ||
| Q1 25 | $37.1M | $-102.6M | ||
| Q4 24 | $33.6M | $24.7M | ||
| Q3 24 | $33.8M | $-2.5M | ||
| Q2 24 | $32.1M | $3.7M | ||
| Q1 24 | $29.0M | $13.6M |
| Q4 25 | 35.6% | 74.8% | ||
| Q3 25 | 35.7% | 73.2% | ||
| Q2 25 | 36.4% | 72.1% | ||
| Q1 25 | 35.2% | 73.1% | ||
| Q4 24 | 36.0% | 73.5% | ||
| Q3 24 | 35.6% | 73.4% | ||
| Q2 24 | 35.5% | 72.5% | ||
| Q1 24 | 34.0% | 72.9% |
| Q4 25 | 19.8% | -8.5% | ||
| Q3 25 | 20.4% | 18.8% | ||
| Q2 25 | 20.1% | 15.1% | ||
| Q1 25 | 20.4% | 12.2% | ||
| Q4 24 | 19.8% | 14.5% | ||
| Q3 24 | 20.0% | 23.9% | ||
| Q2 24 | 19.6% | 20.3% | ||
| Q1 24 | 17.4% | 18.5% |
| Q4 25 | 14.9% | -32.2% | ||
| Q3 25 | 15.1% | 9.0% | ||
| Q2 25 | 15.0% | -14.6% | ||
| Q1 25 | 14.8% | -45.8% | ||
| Q4 24 | 14.0% | 10.0% | ||
| Q3 24 | 14.1% | -1.1% | ||
| Q2 24 | 13.7% | 1.6% | ||
| Q1 24 | 12.1% | 6.1% |
| Q4 25 | $1.21 | $-0.22 | ||
| Q3 25 | $1.24 | $0.05 | ||
| Q2 25 | $1.17 | $-0.08 | ||
| Q1 25 | $1.13 | $-0.25 | ||
| Q4 24 | $1.03 | $0.07 | ||
| Q3 24 | $1.03 | $-0.01 | ||
| Q2 24 | $0.98 | $0.01 | ||
| Q1 24 | $0.89 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.6M | $90.2M |
| Total DebtLower is stronger | — | $1.3B |
| Stockholders' EquityBook value | $1.3B | $552.5M |
| Total Assets | $1.7B | $3.2B |
| Debt / EquityLower = less leverage | — | 2.30× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $90.2M | ||
| Q3 25 | $65.1M | $109.5M | ||
| Q2 25 | $65.4M | $110.3M | ||
| Q1 25 | $49.9M | $114.6M | ||
| Q4 24 | $49.5M | $121.2M | ||
| Q3 24 | $73.7M | $109.9M | ||
| Q2 24 | $63.7M | $121.7M | ||
| Q1 24 | $60.3M | $134.2M |
| Q4 25 | — | $1.3B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | $1.3B | $552.5M | ||
| Q3 25 | $1.3B | $634.6M | ||
| Q2 25 | $1.3B | $611.2M | ||
| Q1 25 | $1.2B | $593.0M | ||
| Q4 24 | $1.1B | $670.2M | ||
| Q3 24 | $1.2B | $683.4M | ||
| Q2 24 | $1.1B | $654.0M | ||
| Q1 24 | $1.1B | $640.8M |
| Q4 25 | $1.7B | $3.2B | ||
| Q3 25 | $1.7B | $2.6B | ||
| Q2 25 | $1.7B | $2.6B | ||
| Q1 25 | $1.6B | $2.6B | ||
| Q4 24 | $1.6B | $2.6B | ||
| Q3 24 | $1.6B | $2.6B | ||
| Q2 24 | $1.6B | $2.6B | ||
| Q1 24 | $1.6B | $2.6B |
| Q4 25 | — | 2.30× | ||
| Q3 25 | — | 2.11× | ||
| Q2 25 | — | 2.19× | ||
| Q1 25 | — | 2.21× | ||
| Q4 24 | — | 1.96× | ||
| Q3 24 | — | 1.97× | ||
| Q2 24 | — | 2.06× | ||
| Q1 24 | — | 2.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $67.3M | $20.6M |
| Free Cash FlowOCF − Capex | — | $7.7M |
| FCF MarginFCF / Revenue | — | 2.7% |
| Capex IntensityCapex / Revenue | — | 4.6% |
| Cash ConversionOCF / Net Profit | 1.72× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $5.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $67.3M | $20.6M | ||
| Q3 25 | $65.6M | $22.6M | ||
| Q2 25 | $47.3M | $6.5M | ||
| Q1 25 | $36.5M | $15.4M | ||
| Q4 24 | $52.3M | $39.7M | ||
| Q3 24 | $51.3M | $10.7M | ||
| Q2 24 | $45.0M | $46.4M | ||
| Q1 24 | $33.4M | $21.5M |
| Q4 25 | — | $7.7M | ||
| Q3 25 | — | $7.9M | ||
| Q2 25 | — | $-9.6M | ||
| Q1 25 | — | $-322.0K | ||
| Q4 24 | — | $24.6M | ||
| Q3 24 | — | $-1.8M | ||
| Q2 24 | — | $31.1M | ||
| Q1 24 | — | $7.1M |
| Q4 25 | — | 2.7% | ||
| Q3 25 | — | 3.3% | ||
| Q2 25 | — | -4.1% | ||
| Q1 25 | — | -0.1% | ||
| Q4 24 | — | 9.9% | ||
| Q3 24 | — | -0.8% | ||
| Q2 24 | — | 13.6% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | — | 4.6% | ||
| Q3 25 | — | 6.1% | ||
| Q2 25 | — | 6.9% | ||
| Q1 25 | — | 7.0% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | — | 5.2% | ||
| Q2 24 | — | 6.7% | ||
| Q1 24 | — | 6.5% |
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | 1.05× | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.56× | 1.61× | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | 12.59× | ||
| Q1 24 | 1.15× | 1.58× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
GETY
| Creative | $149.0M | 53% |
| Editorial | $109.4M | 39% |
| Other | $23.9M | 8% |
